# INFUSYSTEM HOLDINGS, INC (INFU) · Edgar & Edgarette company card

> Infusystem Holdings (INFU) grew revenue 6.4% in FY2025 to $143 million, operating margin 8.3% against a 1.2% median for surgical & medical instruments & apparatus, equity 57.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1337013 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/INFU) · [JSON](https://www.pops4.com/boards/company/INFU.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $143M |
| Revenue growth, 1 year | 6.4% |
| Revenue growth per year | 8.8% |
| Operating margin | 8.3% (prior year 5.1%) |
| Net margin | 4.6% |
| Operating cash flow | $24M |
| Capital spending | $560,000 |
| Free cash flow | $24M |
| Cash | $3M |
| Long-term debt | $20M |
| Total assets | $101M |
| Total equity | $57M |
| Equity ÷ assets | 57.0% |
| Return on equity | 11.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 1.27 (grey zone)
- Piotroski F: 8 of 9 (strong)
- Beneish M: -3.3 (below the −1.78 line)
- Health Harbor boat: Sound ship · one warning sign · filed auditor change in the last 12 months
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $143.4M (FY2025), total debt $19.6M. Experience: revenue up 6.4% on the year, up 8.8% a year over 4 years; operating margin 8.3%, up from 5.1%. Soundness: equity 57.0% of assets, return on equity 11.6%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $133.7M and $171.7M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $125.5M to $183.3M. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin 8.3% against a 1.2% median; growth 6.4% against 11.6%.

Range logged 2026-09-29, receipt f214c1dbd7744585, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 4.01 Auditor change: 1, latest 2026-03-19 ([filing](https://www.sec.gov/Archives/edgar/data/1337013/000162828026019649/0001628280-26-019649-index.htm))
- Item 5.02 Director or officer change: 2, latest 2026-05-14 ([filing](https://www.sec.gov/Archives/edgar/data/1337013/000162828026034839/0001628280-26-034839-index.htm))

## Recent filings

- 8-K · filed 2026-11-03 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1337013/000162828026069113/0001628280-26-069113-index.htm)
- 8-K · filed 2026-10-27 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1337013/000162828026067390/0001628280-26-067390-index.htm)
- 8-K · filed 2026-09-17 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1337013/000162828026062520/0001628280-26-062520-index.htm)
- 10-Q · filed 2026-08-04 · [filing](https://www.sec.gov/Archives/edgar/data/1337013/000162828026052462/0001628280-26-052462-index.htm)
- 8-K · filed 2026-08-04 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1337013/000162828026052123/0001628280-26-052123-index.htm)
- 8-K · filed 2026-08-04 · 2.02 Results of Operations and Financial Condition · [filing](https://www.sec.gov/Archives/edgar/data/1337013/000162828026052112/0001628280-26-052112-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001337013.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1337013

## Cite

POPS4, Edgar & Edgarette: INFUSYSTEM HOLDINGS, INC (INFU) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/INFU. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.